Murine models for mucosal tolerance in allergy

Seminars in Immunology

Volumn 30, Issue , 2017, Pages 12-27

  Smole, Ursula ^a   Schabussova, Irma ^b   Pickl, Winfried F ^a   Wiedermann, Ursula ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; Animal models; BALT; Commensals; GALT; Mucosal tolerance; NALT; Regulatory T cells

Indexed keywords

AEROALLERGEN; ALLERGEN; BACTERIAL TOXIN; CHITIN; CHITOSAN; CHOLERA TOXIN B SUBUNIT; CPG OLIGODEOXYNUCLEOTIDE; LYMPHOTOXIN; PROBIOTIC AGENT; RECOMBINANT ALLERGEN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ALLERGIC ASTHMA; ALLERGY; BRONCHUS; FOOD ALLERGY; IMMUNOLOGICAL TOLERANCE; INTESTINE LYMPHATIC TISSUE; MICROBIOME; MOUSE MODEL; MURINE MODEL; NONHUMAN; NOSE; PARASITE; RESPIRATORY TRACT ALLERGY; REVIEW; SENSITIZATION; ANIMAL; DESENSITIZATION; DISEASE MODEL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; INTESTINE; MOUSE; MUCOSA; MUCOSAL IMMUNITY; PROCEDURES; RESPIRATORY SYSTEM;

ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTESTINES; MICE; MUCOUS MEMBRANE; RESPIRATORY SYSTEM;

EID: 85028332947     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.07.007     Document Type: Review

References (278)

1. Belkaid, Y., Artis, D., Immunity at the barriers. Eur. J. Immunol. 43:12 (2013), 3096–3097.
2. Berin, M.C., Sampson, H.A., Mucosal immunology of food allergy. Curr. Biol. 23:9 (2013), R389–400.
3. Hammad, H., Lambrecht, B.N., Barrier epithelial cells and the control of type 2 immunity. Immunity 43:1 (2015), 29–40.
4. Lefrancois, L., Puddington, L., Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu. Rev. Immunol. 24 (2006), 681–704.
5. Akdis, C.A., Akdis, M., Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J. Clin. Invest. 124:11 (2014), 4678–4680.
6. Berin, M.C., Shreffler, W.G., Mechanisms underlying induction of tolerance to foods. Immunol. Allergy Clin. North. Am. 36:1 (2016), 87–102.
7. Soyer, O.U., Akdis, M., Ring, J., Behrendt, H., Crameri, R., Lauener, R., Akdis, C.A., Mechanisms of peripheral tolerance to allergens. Allergy 68:2 (2013), 161–170.
8. Lambrecht, B.N., Hammad, H., Allergens and the airway epithelium response: gateway to allergic sensitization. J. Allergy Clin. Immunol. 134:3 (2014), 499–507.
9. Hristova, M., Habibovic, A., Veith, C., Janssen-Heininger, Y.M., Dixon, A.E., Geiszt, M., van der Vliet, A., Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses. J. Allergy Clin. Immunol. 137:5 (2016), 1545–1556.
10. Schuijs, M.J., Willart, M.A., Vergote, K., Gras, D., Deswarte, K., Ege, M.J., Madeira, F.B., Beyaert, R., van Loo, G., Bracher, F., von Mutius, E., Chanez, P., Lambrecht, B.N., Hammad, H., Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349:6252 (2015), 1106–1110.
11. Willart, M.A., Deswarte, K., Pouliot, P., Braun, H., Beyaert, R., Lambrecht, B.N., Hammad, H., Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 209:8 (2012), 1505–1517.
12. Vickery, B.P., Burks, A.W., Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr. Opin. Allergy Clin. Immunol. 9:4 (2009), 364–370.
13. Dakin, R., Remarks on a cutaneous affection, produced by certain poisonous vegetables. Am. J. Med. Sci. 4 (1829), 98–100.
14. Wells, H.G., Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. J. Infect. Dis. 9:2 (1911), 147–171.
15. Wells, H.G., Osborne, T.B., The biological reactions of the vegetable proteins. I. Anaphylaxis. J. Infect Dis. 8:1 (1911), 66–124.
16. Bienenstock, J., Befus, A.D., Mucosal immunology. Immunology 41:2 (1980), 249–270.
17. McDermott, M.R., Bienenstock, J., Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:5 (1979), 1892–1898.
18. Pabst, O., Mowat, A.M., Oral tolerance to food protein. Mucosal Immunol. 5:3 (2012), 232–239.
19. Weiner, H.L., da Cunha, A.P., Quintana, F., Wu, H., Oral tolerance. Immunol. Rev. 241:1 (2011), 241–259.
20. Tulic, M.K., Piche, T., Verhasselt, V., Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. Clin. Exp. Allergy 46:4 (2016), 519–528.
21. Curotto de Lafaille, M.A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., Lafaille, J.J., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29:1 (2008), 114–126.
22. Curotto de Lafaille, M.A., Lafaille, J.J., Graca, L., Mechanisms of tolerance and allergic sensitization in the airways and the lungs. Curr. Opin. Immunol. 22:5 (2010), 616–622.
23. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J.J., Curotto de Lafaille, M.A., Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115:7 (2005), 1923–1933.
24. Appleman, L.J., Boussiotis, V.A., T cell anergy and costimulation. Immunol. Rev. 192 (2003), 161–180.
25. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V.K., Weiner, H.L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:6536 (1995), 177–180.
26. Samoilova, E.B., Horton, J.L., Zhang, H., Khoury, S.J., Weiner, H.L., Chen, Y., CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10:4 (1998), 491–498.
27. Mayer, L., Shao, L., Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4:6 (2004), 407–419.
28. Melamed, D., Friedman, A., Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23:4 (1993), 935–942.
29. Friedman, A., Weiner, H.L., Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. U. S. A. 91:14 (1994), 6688–6692.
30. Yoshida, T., Hachimura, S., Kaminogawa, S., The oral administration of low-dose antigen induces activation followed by tolerization, while high-dose antigen induces tolerance without activation. Clin. Immunol. Immunopathol. 82:3 (1997), 207–215.
31. Chen, Y., Inobe, J., Kuchroo, V.K., Baron, J.L., Janeway, C.A. Jr., Weiner, H.L., Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. U. S. A. 93:1 (1996), 388–391.
32. Mowat, A.M., The role of antigen recognition and suppressor cells in mice with oral tolerance to ovalbumin. Immunology 56:2 (1985), 253–260.
33. Mowat, A.M., Thomas, M.J., MacKenzie, S., Parrott, D.M., Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice. Immunology 58:4 (1986), 677–683.
34. Polovic, N., Velickovic, T.C., Novel formulations for oral allergen vaccination. Recent Pat. Inflamm. Allergy Drug Discov. 2:3 (2008), 215–221.
35. Nowak-Wegrzyn, A., Sampson, H.A., Future therapies for food allergies. J. Allergy Clin. Immunol. 127:3 (2011), 558–573.
36. Moran, T.P., Burks, A.W., Is clinical tolerance possible after allergen immunotherapy?. Curr. Allergy Asthma Rep., 15(5), 2015, 23.
37. Gensollen, T., Iyer, S.S., Kasper, D.L., Blumberg, R.S., How colonization by microbiota in early life shapes the immune system. Science 352:6285 (2016), 539–544.
38. Gollwitzer, E.S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K.D., Nicod, L.P., Lloyd, C.M., Marsland, B.J., Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat. Med. 20:6 (2014), 642–647.
39. Marsland, B.J., Trompette, A., Gollwitzer, E.S., The gut-lung axis in respiratory disease. Ann. Am. Thorac. Soc. 12:Suppl. 2 (2015), S150–156.
40. Wesemann, D.R., Nagler, C.R., The microbiome, timing, and barrier function in the context of allergic disease. Immunity 44:4 (2016), 728–738.
41. Mowat, A.M., Agace, W.W., Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14:10 (2014), 667–685.
42. Berg, R.D., The indigenous gastrointestinal microflora. Trends Microbiol. 4:11 (1996), 430–435.
43. Collier-Hyams, L.S., Sloane, V., Batten, B.C., Neish, A.S., Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J. Immunol. 175:7 (2005), 4194–4198.
44. Collier-Hyams, L.S., Neish, A.S., Innate immune relationship between commensal flora and the mammalian intestinal epithelium. Cell. Mol. Life Sci. 62:12 (2005), 1339–1348.
45. Rescigno, M., Gut commensal flora: tolerance and homeostasis. F1000 Biol. Rep., 1, 2009, 9.
46. Zeuthen, L.H., Fink, L.N., Frokiaer, H., Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology 123:2 (2008), 197–208.
47. Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., Mantegazza, A.R., Ma, H.L., Crawford, A., Angelosanto, J.M., Wherry, E.J., Koni, P.A., Bushman, F.D., Elson, C.O., Eberl, G., Artis, D., Sonnenberg, G.F., Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498:7452 (2013), 113–117.
48. Chung, H., Pamp, S.J., Hill, J.A., Surana, N.K., Edelman, S.M., Troy, E.B., Reading, N.C., Villablanca, E.J., Wang, S., Mora, J.R., Umesaki, Y., Mathis, D., Benoist, C., Relman, D.A., Kasper, D.L., Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149:7 (2012), 1578–1593.
49. Muir, A.B., Benitez, A.J., Dods, K., Spergel, J.M., Fillon, S.A., Microbiome and its impact on gastrointestinal atopy. Allergy 71:9 (2016), 1256–1263.
50. Bashir, M.E., Louie, S., Shi, H.N., Nagler-Anderson, C., Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 172:11 (2004), 6978–6987.
51. Hill, D.A., Siracusa, M.C., Abt, M.C., Kim, B.S., Kobuley, D., Kubo, M., Kambayashi, T., Larosa, D.F., Renner, E.D., Orange, J.S., Bushman, F.D., Artis, D., Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 18:4 (2012), 538–546.
52. Kim, K.S., Hong, S.W., Han, D., Yi, J., Jung, J., Yang, B.G., Lee, J.Y., Lee, M., Surh, C.D., Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351:6275 (2016), 858–863.
53. Kim, K.S., Surh, C.D., Induction of immune tolerance to dietary antigens. Adv. Exp. Med. Biol. 850 (2015), 93–118.
54. Brandtzaeg, P., Homeostatic impact of indigenous microbiota and secretory immunity. Beneficial Microbes 1:3 (2010), 211–227.
55. Tsuda, M., Hosono, A., Yanagibashi, T., Kihara-Fujioka, M., Hachimura, S., Itoh, K., Hirayama, K., Takahashi, K., Kaminogawa, S., Intestinal commensal bacteria promote T cell hyporesponsiveness and down-regulate the serum antibody responses induced by dietary antigen. Immunol. Lett. 132:1–2 (2010), 45–52.
56. Repa, A., Kozakova, H., Hudcovic, T., Stepankova, R., Hrncir, T., Tlaskalova-Hogenova, H., Pollak, A., Wiedermann, U., Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol. Lett. 117:1 (2008), 50–56.
57. Walton, K.L., Galanko, J.A., Balfour Sartor, R., Fisher, N.C., T cell-mediated oral tolerance is intact in germ-free mice. Clin. Exp. Immunol. 143:3 (2006), 503–512.
58. Shouval, D.S., Ouahed, J., Biswas, A., Goettel, J.A., Horwitz, B.H., Klein, C., Muise, A.M., Snapper, S.B., Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv. Immunol. 122 (2014), 177–210.
59. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:2 (1993), 263–274.
60. Sellon, R.K., Tonkonogy, S., Schultz, M., Dieleman, L.A., Grenther, W., Balish, E., Rennick, D.M., Sartor, R.B., Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:11 (1998), 5224–5231.
61. Gicheva, N., Macauley, M.S., Arlian, B.M., Paulson, J.C., Kawasaki, N., Siglec-F is a novel intestinal M cell marker. Biochem. Biophys. Res. Commun. 479:1 (2016), 1–4.
62. Mabbott, N.A., Donaldson, D.S., Ohno, H., Williams, I.R., Mahajan, A., Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 6:4 (2013), 666–677.
63. Bjarnason, I., MacPherson, A., Hollander, D., Intestinal permeability: an overview. Gastroenterology 108:5 (1995), 1566–1581.
64. Hu, G., Gong, A.Y., Roth, A.L., Huang, B.Q., Ward, H.D., Zhu, G., Larusso, N.F., Hanson, N.D., Chen, X.M., Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog., 9(4), 2013, e1003261.
65. Smythies, L.E., Smythies, J.R., Exosomes in the gut. Front. Immunol., 5, 2014, 104.
66. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.P., Ricciardi-Castagnoli, P., Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:4 (2001), 361–367.
67. Schulz, O., Jaensson, E., Persson, E.K., Liu, X., Worbs, T., Agace, W.W., Pabst, O., Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med. 206:13 (2009), 3101–3114.
68. Cerovic, V., Houston, S.A., Scott, C.L., Aumeunier, A., Mowat, A.M., Milling, S.W.F., Intestinal CD103-dendritic cells migrate in lymph and prime effector T cells. Immunology, 137, 2012, 35.
69. Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., Powrie, F., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:8 (2007), 1757–1764.
70. Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes, J.L., Berg, P.L., Davidsson, T., Powrie, F., Johansson-Lindbom, B., Agace, W.W., Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205:9 (2008), 2139–2149.
71. Pabst, O., Bernhardt, G., Forster, R., The impact of cell-bound antigen transport on mucosal tolerance induction. J. Leukoc. Biol. 82:4 (2007), 795–800.
72. Worbs, T., Bode, U., Yan, S., Hoffmann, M.W., Hintzen, G., Bernhardt, G., Forster, R., Pabst, O., Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203:3 (2006), 519–527.
73. Macpherson, A.J., Uhr, T., Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann. N. Y. Acad. Sci. 1029 (2004), 36–43.
74. Mowat, A.M., Donachie, A.M., Parker, L.A., Robson, N.C., Beacock-Sharp, H., McIntyre, L.J., Millington, O., Chirdo, F., The role of dendritic cells in regulating mucosal immunity and tolerance. Novartis Found. Symp. 252 (2003), 291–302 discussion 302–305.
75. Iliev, I.D., Spadoni, I., Mileti, E., Matteoli, G., Sonzogni, A., Sampietro, G.M., Foschi, D., Caprioli, F., Viale, G., Rescigno, M., Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 58:11 (2009), 1481–1489.
76. Collins, C.B., Aherne, C.M., Kominsky, D., McNamee, E.N., Lebsack, M.D., Eltzschig, H., Jedlicka, P., Rivera-Nieves, J., Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology 141:5 (2011), 1821–1831.
77. Hammerschmidt, S.I., Ahrendt, M., Bode, U., Wahl, B., Kremmer, E., Forster, R., Pabst, O., Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J. Exp. Med. 205:11 (2008), 2483–2490.
78. Pino-Lagos, K., Guo, Y., Brown, C., Alexander, M.P., Elgueta, R., Bennett, K.A., De Vries, V., Nowak, E., Blomhoff, R., Sockanathan, S., Chandraratna, R.A., Dmitrovsky, E., Noelle, R.J., A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. J. Exp. Med. 208:9 (2011), 1767–1775.
79. Spahn, T.W., Weiner, H.L., Rennert, P.D., Lugering, N., Fontana, A., Domschke, W., Kucharzik, T., Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32:4 (2002), 1109–1113.
80. Johansson-Lindbom, B., Svensson, M., Pabst, O., Palmqvist, C., Marquez, G., Forster, R., Agace, W.W., Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202:8 (2005), 1063–1073.
81. Berlin, C., Berg, E.L., Briskin, M.J., Andrew, D.P., Kilshaw, P.J., Holzmann, B., Weissman, I.L., Hamann, A., Butcher, E.C., Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:1 (1993), 185–195.
82. Hadis, U., Wahl, B., Schulz, O., Hardtke-Wolenski, M., Schippers, A., Wagner, N., Muller, W., Sparwasser, T., Forster, R., Pabst, O., Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34:2 (2011), 237–246.
83. Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., Song, S.Y., Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:4 (2004), 527–538.
84. Benson, M.J., Pino-Lagos, K., Rosemblatt, M., Noelle, R.J., All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204:8 (2007), 1765–1774.
85. Weber, B., Saurer, L., Schenk, M., Dickgreber, N., Mueller, C., CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur. J. Immunol. 41:3 (2011), 773–779.
86. Dubois, B., Joubert, G., Gomez de Aguero, M., Gouanvic, M., Goubier, A., Kaiserlian, D., Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 137:3 (2009), 1019–1028.
87. Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G., Kaiserlian, D., Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29:3 (2008), 464–475.
88. Harrison, L.C., Dempsey-Collier, M., Kramer, D.R., Takahashi, K., Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:6 (1996), 2167–2174.
89. Tian, J., Atkinson, M.A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P.V., Kaufman, D.L., Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:4 (1996), 1561–1567.
90. Shi, F.D., Li, H., Wang, H., Bai, X., van der Meide, P.H., Link, H., Ljunggren, H.G., Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. J. Immunol. 162:10 (1999), 5757–5763.
91. Khare, A., Krishnamoorthy, N., Oriss, T.B., Fei, M., Ray, P., Ray, A., Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance. J. Immunol. 191:1 (2013), 25–29.
92. Smith, D.J., Bot, S., Dellamary, L., Bot, A., Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Vaccine 21:21–22 (2003), 2805–2812.
93. Brandtzaeg, P., Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am. J. Respir. Crit. Care Med. 183:12 (2011), 1595–1604.
94. Heritage, P.L., Underdown, B.J., Arsenault, A.L., Snider, D.P., McDermott, M.R., Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am. J. Respir. Crit. Care Med. 156:4 Pt 1 (1997), 1256–1262.
95. Kuper, C.F., Koornstra, P.J., Hameleers, D.M., Biewenga, J., Spit, B.J., Duijvestijn, A.M., van Breda Vriesman, P.J., Sminia, T., The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:6 (1992), 219–224.
96. Pabst, R., Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences. Vaccine 33:36 (2015), 4406–4413.
97. Debertin, A.S., Tschernig, T., Tonjes, H., Kleemann, W.J., Troger, H.D., Pabst, R., Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin. Exp. Immunol. 134:3 (2003), 503–507.
98. Wolvers, D.A., Coenen-de Roo, C.J., Mebius, R.E., van der Cammen, M.J., Tirion, F., Miltenburg, A.M., Kraal, G., Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J. Immunol. 162:4 (1999), 1994–1998.
99. Bienenstock, J., McDermott, M.R., Bronchus- and nasal-associated lymphoid tissues. Immunol. Rev. 206 (2005), 22–31.
100. Delventhal, S., Brandis, A., Ostertag, H., Pabst, R., Low incidence of bronchus-associated lymphoid tissue (BALT) in chronically inflamed human lungs. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 62:4 (1992), 271–274.
101. Pabst, R., Gehrke, I., Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?. Am. J. Respir. Cell Mol. Biol. 3:2 (1990), 131–135.
102. Gould, S.J., Isaacson, P.G., Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung. J. Pathol. 169:2 (1993), 229–234.
103. Hiller, A.S., Tschernig, T., Kleemann, W.J., Pabst, R., Bronchus-associated lymphoid tissue (BALT) and larynx-associated lymphoid tissue (LALT) are found at different frequencies in children, adolescents and adults. Scand. J. Immunol. 47:2 (1998), 159–162.
104. Tschernig, T., Pabst, R., Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 68:1 (2000), 1–8.
105. Rangel-Moreno, J., Carragher, D.M., de la Luz Garcia-Hernandez, M., Hwang, J.Y., Kusser, K., Hartson, L., Kolls, J.K., Khader, S.A., Randall, T.D., The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12:7 (2011), 639–646.
106. Mantis, N.J., Rol, N., Corthesy, B., Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4:6 (2011), 603–611.
107. Waldman, R.H., Henney, C.S., Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J. Exp. Med. 134:2 (1971), 482–494.
108. de Heer, H.J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M.A., Hoogsteden, H.C., Lambrecht, B.N., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200:1 (2004), 89–98.
109. Guilliams, M., Crozat, K., Henri, S., Tamoutounour, S., Grenot, P., Devilard, E., de Bovis, B., Alexopoulou, L., Dalod, M., Malissen, B., Skin-draining lymph nodes contain dermis-derived CD103(−) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 115:10 (2010), 1958–1968.
110. Lombardi, V., Speak, A.O., Kerzerho, J., Szely, N., Akbari, O., CD8alpha(+)beta(−) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol. 5:4 (2012), 432–443.
111. Plantinga, M., Guilliams, M., Vanheerswynghels, M., Deswarte, K., Branco-Madeira, F., Toussaint, W., Vanhoutte, L., Neyt, K., Killeen, N., Malissen, B., Hammad, H., Lambrecht, B.N., Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38:2 (2013), 322–335.
112. McMenamin, C., McKersey, M., Kuhnlein, P., Hunig, T., Holt, P.G., Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J. Immunol. 154:9 (1995), 4390–4394.
113. McMenamin, C., Pimm, C., McKersey, M., Holt, P.G., Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 265:5180 (1994), 1869–1871.
114. Jeong, K.I., Suzuki, H., Nakayama, H., Doi, K., Ultrastructural study on the follicle-associated epithelium of nasal-associated lymphoid tissue in specific pathogen-free (SPF) and conventional environment-adapted (SPF-CV) rats. J. Anat. 196:Pt 3 (2000), 443–451.
115. Brandtzaeg, P., History of oral tolerance and mucosal immunity. Ann. N. Y. Acad. Sci. 778 (1996), 1–27.
116. Lee, H., Ruane, D., Law, K., Ho, Y., Garg, A., Rahman, A., Esterhazy, D., Cheong, C., Goljo, E., Sikora, A.G., Mucida, D., Chen, B.K., Govindraj, S., Breton, G., Mehandru, S., Phenotype and function of nasal dendritic cells. Mucosal Immunol. 8:5 (2015), 1083–1098.
117. Sedgwick, J.D., Holt, P.G., Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell. Immunol. 94:1 (1985), 182–194.
118. Samsom, J.N., van der Marel, A.P., van Berkel, L.A., van Helvoort, J.M., Simons-Oosterhuis, Y., Jansen, W., Greuter, M., Nelissen, R.L., Meeuwisse, C.M., Nieuwenhuis, E.E., Mebius, R.E., Kraal, G., Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance. J. Immunol. 179:10 (2007), 6588–6595.
119. Reardon, C., Lechmann, M., Brustle, A., Gareau, M.G., Shuman, N., Philpott, D., Ziegler, S.F., Mak, T.W., Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity 35:2 (2011), 223–235.
120. Garside, P., Mowat, A.M., Khoruts, A., Oral tolerance in disease. Gut 44:1 (1999), 137–142.
121. Higgins, P.J., Weiner, H.L., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:2 (1988), 440–445.
122. Nagler-Anderson, C., Bober, L.A., Robinson, M.E., Siskind, G.W., Thorbecke, G.J., Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. U. S. A. 83:19 (1986), 7443–7446.
123. Zellweger, F., Eggel, A., IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment. Allergy 71:12 (2016), 1652–1661.
124. Holt, P.G., Batty, J.E., Turner, K.J., Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 42:3 (1981), 409–417.
125. Keller, A.C., Mucida, D., Gomes, E., Faquim-Mauro, E., Faria, A.M., Rodriguez, D., Russo, M., Hierarchical suppression of asthma-like responses by mucosal tolerance. J. Allergy Clin. Immunol. 117:2 (2006), 283–290.
126. Wiedermann, U., Herz, U., Baier, K., Vrtala, S., Neuhaus-Steinmetz, U., Bohle, B., Dekan, G., Renz, H., Ebner, C., Valenta, R., Kraft, D., Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int. Arch. Allergy Immunol. 126:1 (2001), 68–77.
127. Wiedermann, U., Jahn-Schmid, B., Bohle, B., Repa, A., Renz, H., Kraft, D., Ebner, C., Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J. Allergy Clin. Immunol. 103:6 (1999), 1202–1210.
128. Hufnagl, K., Focke, M., Gruber, F., Hufnagl, P., Loupal, G., Scheiner, O., Wiedermann, U., Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides. Clin. Exp. Allergy 38:7 (2008), 1192–1202.
129. Hufnagl, K., Wagner, B., Winkler, B., Baier, K., Hochreiter, R., Thalhamer, J., Kraft, D., Scheiner, O., Breiteneder, H., Wiedermann, U., Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice. Clin. Exp. Immunol. 133:2 (2003), 170–176.
130. Mascarell, L., Zimmer, A., Van Overtvelt, L., Tourdot, S., Moingeon, P., Induction of allergen-specific tolerance via mucosal routes. Curr. Top. Microbiol. Immunol. 352 (2011), 85–105.
131. Moingeon, P., Lombardi, V., Baron-Bodo, V., Mascarell, L., Enhancing allergen-presentation platforms for sublingual immunotherapy. J. Allergy Clin. Immunol. Pract. 5:1 (2017), 23–31.
132. Sun, J.B., Czerkinsky, C., Holmgren, J., Sublingual ‘oral tolerance’ induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand. J. Immunol. 66:2-3 (2007), 278–286.
133. Sun, J.B., Czerkinsky, C., Holmgren, J., Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand. J. Immunol. 71:1 (2010), 1–11.
134. Valenta, R., Campana, R., Focke-Tejkl, M., Niederberger, V., Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future. J. Allergy Clin. Immunol. 137:2 (2016), 351–357.
135. Jutel, M., Jaeger, L., Suck, R., Meyer, H., Fiebig, H., Cromwell, O., Allergen-specific immunotherapy with recombinant grass pollen allergens. J. Allergy Clin. Immunol. 116:3 (2005), 608–613.
136. Pauli, G., Larsen, T.H., Rak, S., Horak, F., Pastorello, E., Valenta, R., Purohit, A., Arvidsson, M., Kavina, A., Schroeder, J.W., Mothes, N., Spitzauer, S., Montagut, A., Galvain, S., Melac, M., Andre, C., Poulsen, L.K., Malling, H.J., Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 122:5 (2008), 951–960.
137. Linhart, B., Valenta, R., Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine 30:29 (2012), 4328–4335.
138. Chapman, D.G., Tully, J.E., Nolin, J.D., Janssen-Heininger, Y.M., Irvin, C.G., Animal models of allergic airways disease: where are we and where to next?. J. Cell. Biochem. 115:12 (2014), 2055–2064.
139. Herz, U., Renz, H., Wiedermann, U., Animal models of type I allergy using recombinant allergens. Methods 32:3 (2004), 271–280.
140. Marques-Garcia, F., Marcos-Vadillo, E., Review of mouse models applied to the study of asthma. Methods Mol. Biol. 1434 (2016), 213–222.
141. McMillan, S.J., Lloyd, C.M., Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin. Exp. Allergy 34:3 (2004), 497–507.
142. Ewart, S.L., Kuperman, D., Schadt, E., Tankersley, C., Grupe, A., Shubitowski, D.M., Peltz, G., Wills-Karp, M., Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am. J. Respir. Cell Mol. Biol. 23:4 (2000), 537–545.
143. Karol, M.H., Animal models of occupational asthma. Eur. Respir. J. 7:3 (1994), 555–568.
144. Kumar, R.K., Herbert, C., Foster, P.S., The classical ovalbumin challenge model of asthma in mice. Curr. Drug Targets 9:6 (2008), 485–494.
145. Marth, T., Ring, S., Schulte, D., Klensch, N., Strober, W., Kelsall, B.L., Stallmach, A., Zeitz, M., Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice. Eur. J. Immunol. 30:12 (2000), 3478–3486.
146. Jacquet, A., The role of innate immunity activation in house dust mite allergy. Trends Mol. Med. 17:10 (2011), 604–611.
147. Wiedermann, U., Jahn-Schmid, B., Lindblad, M., Rask, C., Holmgren, J., Kraft, D., Ebner, C., Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int. Immunol. 11:7 (1999), 1131–1138.
148. Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., Lambrecht, B.N., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15:4 (2009), 410–416.
149. Borish, L.C., Nelson, H.S., Lanz, M.J., Claussen, L., Whitmore, J.B., Agosti, J.M., Garrison, L., Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160:6 (1999), 1816–1823.
150. Kips, J.C., Anderson, G.P., Fredberg, J.J., Herz, U., Inman, M.D., Jordana, M., Kemeny, D.M., Lotvall, J., Pauwels, R.A., Plopper, C.G., Schmidt, D., Sterk, P.J., Van Oosterhout, A.J., Vargaftig, B.B., Chung, K.F., Murine models of asthma. Eur. Respir. J. 22:2 (2003), 374–382.
151. Leckie, M.J., Chronic allergen challenge as an experimental model: necessary, significant or useful?. Clin. Exp. Allergy 30:9 (2000), 1191–1193.
152. Winkler, B., Hufnagl, K., Spittler, A., Ploder, M., Kallay, E., Vrtala, S., Valenta, R., Kundi, M., Renz, H., Wiedermann, U., The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Allergy 61:2 (2006), 173–180.
153. Wiedermann, U., Herz, U., Vrtala, S., Neuhaus-Steinmetz, U., Renz, H., Ebner, C., Valenta, R., Kraft, D., Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma. Int. Arch. Allergy Immunol. 124:1–3 (2001), 391–394.
154. Hufnagl, K., Winkler, B., Focke, M., Valenta, R., Scheiner, O., Renz, H., Wiedermann, U., Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 116:2 (2005), 370–376.
155. Marazuela, E.G., Rodriguez, R., Fernandez-Garcia, H., Garcia, M.S., Villalba, M., Batanero, E., Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen. Mol. Immunol. 45:2 (2008), 438–445.
156. Palomares, O., Batanero, E., Canamero, M., Villalba, M., Rodriguez, R., Prophylactic intranasal treatment with fragments of 1,3-beta-glucanase olive pollen allergen prevents airway inflammation in a murine model of type I allergy. Int. Arch. Allergy Immunol. 139:3 (2006), 175–180.
157. Villalba, M., Rodriguez, R., Batanero, E., The spectrum of olive pollen allergens. From structures to diagnosis and treatment. Methods 66:1 (2014), 44–54.
158. Clarke, A.H., O'Brien, R.M., Rolland, J.M., Thomas, W.R., Allergic respiratory responses to Der p 1 in mice. Int. Arch. Allergy Immunol. 118:2–4 (1999), 287–288.
159. Hoyne, G.F., O'Hehir, R.E., Wraith, D.C., Thomas, W.R., Lamb, J.R., Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:5 (1993), 1783–1788.
160. Jarnicki, A.G., Tsuji, T., Thomas, W.R., Inhibition of mucosal and systemic T(h)2-type immune responses by intranasal peptides containing a dominant T cell epitope of the allergen Der p 1. Int. Immunol. 13:10 (2001), 1223–1231.
161. Johansson, L., Svensson, L., Bergstrom, U., Jacobsson-Ekman, G., Arner, E.S., van Hage, M., Bucht, A., Gafvelin, G., A mouse model for in vivo tracking of the major dust mite allergen Der p 2 after inhalation. FEBS J. 272:13 (2005), 3449–3460.
162. Ou-Yang, H.F., Hu, X.B., Ti, X.Y., Shi, J.R., Li, S.J., Qi, H.W., Wu, C.G., Suppression of allergic airway inflammation in a mouse model by Der p2 recombined BCG. Immunology 128:1 Suppl (2009), e343–352.
163. Szalai, K., Kopp, T., Lukschal, A., Stremnitzer, C., Wallmann, J., Starkl, P., Vander Elst, L., Saint-Remy, J.M., Pali-Scholl, I., Jensen-Jarolim, E., Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice. Exp. Dermatol. 21:11 (2012), 842–846.
164. Dullaers, M., Schuijs, M.J., Willart, M., Fierens, K., Van Moorleghem, J., Hammad, H., Lambrecht, B.N., House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting. J. Allergy Clin. Immunol. 140:1 (2017), 76–88.
165. Haspeslagh, E., Debeuf, N., Hammad, H., Lambrecht, B.N., Murine models of allergic asthma. Methods Mol. Biol. 1559 (2017), 121–136.
166. Vroman, H., Bergen, I.M., Li, B.W., van Hulst, J.A., Lukkes, M., van Uden, D., Hendriks, R.W., Kool, M., Development of eosinophilic inflammation is independent of B-T cell interaction in a chronic house dust mite-driven asthma model. Clin. Exp. Allergy 47:4 (2017), 551–564.
167. Briner, T.J., Kuo, M.C., Keating, K.M., Rogers, B.L., Greenstein, J.L., Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc. Natl. Acad. Sci. U. S. A. 90:16 (1993), 7608–7612.
168. Campbell, J.D., Buckland, K.F., McMillan, S.J., Kearley, J., Oldfield, W.L., Stern, L.J., Gronlund, H., van Hage, M., Reynolds, C.J., Boyton, R.J., Cobbold, S.P., Kay, A.B., Altmann, D.M., Lloyd, C.M., Larche, M., Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 206:7 (2009), 1535–1547.
169. Prickett, S.R., Rolland, J.M., O'Hehir, R.E., Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy. Clin. Exp. Allergy 45:6 (2015), 1015–1026.
170. Bauer, L., Bohle, B., Jahn-Schmid, B., Wiedermann, U., Daser, A., Renz, H., Kraft, D., Ebner, C., Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin. Exp. Immunol. 107:3 (1997), 536–541.
171. Silvestri, M., Rossi, G.A., Cozzani, S., Pulvirenti, G., Fasce, L., Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann. Allergy Asthma Immunol. 83:4 (1999), 335–340.
172. van Rijt, L.S., Logiantara, A., Utsch, L., Canbaz, D., Boon, L., van Ree, R., House dust mite allergic airway inflammation facilitates neosensitization to inhaled allergen in mice. Allergy 67:11 (2012), 1383–1391.
173. Bohle, B., The impact of pollen-related food allergens on pollen allergy. Allergy 62:1 (2007), 3–10.
174. Mauro, M., Russello, M., Incorvaia, C., Gazzola, G., Frati, F., Moingeon, P., Passalacqua, G., Birch-apple syndrome treated with birch pollen immunotherapy. Int. Arch. Allergy Immunol. 156:4 (2011), 416–422.
175. Hoflehner, E., Hufnagl, K., Schabussova, I., Jasinska, J., Hoffmann-Sommergruber, K., Bohle, B., Maizels, R.M., Wiedermann, U., Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice. PLoS One, 7(6), 2012, e39409.
176. Wiedermann, U., Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs. Curr. Drug Targets Inflamm. Allergy 4:5 (2005), 577–583.
177. Wiedermann, U., Hitting the mucosal road in tolerance induction. Nestle Nutr. Workshop Ser. Pediatr. Program. 64 (2009), 63–74.
178. Hall, G., Houghton, C.G., Rahbek, J.U., Lamb, J.R., Jarman, E.R., Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. Vaccine, 21(5–6), 2003 5495–5461.
179. O'Hehir, R.E., Prickett, S.R., Rolland, J.M., T cell epitope peptide therapy for allergic diseases. Curr. Allergy Asthma Rep., 16(2), 2016, 14.
180. Yasue, M., Yokota, T., Fukada, M., Takai, T., Suko, M., Okudaira, H., Okumura, Y., Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S. Clin. Exp. Immunol. 113:1 (1998), 1–9.
181. Astori, M., von Garnier, C., Kettner, A., Dufour, N., Corradin, G., Spertini, F., Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J. Immunol. 165:6 (2000), 3497–3505.
182. Akgun, J., Schabussova, I., Schwarzer, M., Kozakova, H., Kundi, M., Wiedermann, U., The role of alveolar epithelial type II-like cells in uptake of structurally different antigens and in polarisation of local immune responses. PLoS One, 10(4), 2015, e0124777.
183. Miller, A., Lider, O., Weiner, H.L., Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:4 (1991), 791–798.
184. Larche, M., Mechanisms of peptide immunotherapy in allergic airways disease. Ann. Am. Thorac. Soc. 11:Suppl. 5 (2014), S292–296.
185. Worm, M., Patel, D., Creticos, P.S., Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis. Exp. Opin. Invest. Drugs 22:10 (2013), 1347–1357.
186. Wild, C., Wallner, M., Hufnagl, K., Fuchs, H., Hoffmann-Sommergruber, K., Breiteneder, H., Scheiner, O., Ferreira, F., Wiedermann, U., A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities. Allergy 62:1 (2007), 33–41.
187. Challacombe, S.J., Tomasi, T.B. Jr., Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152:6 (1980), 1459–1472.
188. Smits, H.H., Gloudemans, A.K., van Nimwegen, M., Willart, M.A., Soullie, T., Muskens, F., de Jong, E.C., Boon, L., Pilette, C., Johansen, F.E., Hoogsteden, H.C., Hammad, H., Lambrecht, B.N., Cholera toxin B suppresses allergic inflammation through induction of secretory IgA. Mucosal Immunol. 2:4 (2009), 331–339.
189. Kukkonen, K., Kuitunen, M., Haahtela, T., Korpela, R., Poussa, T., Savilahti, E., High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr. Allergy Immunol. 21:1 Pt. 1 (2010), 67–73.
190. Su, S.B., Silver, P.B., Wang, P., Chan, C.C., Caspi, R.R., Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation. J. Immunol. 173:2 (2004), 755–761.
191. Chen, X.W., Lau, K.W., Yang, F., Sun, S.S., Fung, M.C., An adjuvant free mouse model of oral allergenic sensitization to rice seeds protein. BMC Gastroenterol., 11, 2011, 62.
192. Birmingham, N.P., Parvataneni, S., Hassan, H.M., Harkema, J., Samineni, S., Navuluri, L., Kelly, C.J., Gangur, V., An adjuvant-free mouse model of tree nut allergy using hazelnut as a model tree nut. Int. Arch. Allergy Immunol. 144:3 (2007), 203–210.
193. Parvataneni, S., Gonipeta, B., Tempelman, R.J., Gangur, V., Development of an adjuvant-free cashew nut allergy mouse model. Int. Arch. Allergy Immunol. 149:4 (2009), 299–304.
194. Gonipeta, B., Parvataneni, S., Tempelman, R.J., Gangur, V., An adjuvant-free mouse model to evaluate the allergenicity of milk whey protein. J. Dairy Sci. 92:10 (2009), 4738–4744.
195. Gonipeta, B., Parvataneni, S., Paruchuri, P., Gangur, V., Long-term characteristics of hazelnut allergy in an adjuvant-free mouse model. Int. Arch. Allergy Immunol. 152:3 (2010), 219–225.
196. Chen, C.Y., Lee, J.B., Liu, B., Ohta, S., Wang, P.Y., Kartashov, A.V., Mugge, L., Abonia, J.P., Barski, A., Izuhara, K., Rothenberg, M.E., Finkelman, F.D., Hogan, S.P., Wang, Y.H., Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity 43:4 (2015), 788–802.
197. Liu, T., Navarro, S., Lopata, A.L., Current advances of murine models for food allergy. Mol. Immunol. 70 (2016), 104–117.
198. Morafo, V., Srivastava, K., Huang, C.K., Kleiner, G., Lee, S.Y., Sampson, H.A., Li, A.M., Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice. J. Allergy Clin. Immunol. 111:5 (2003), 1122–1128.
199. Roy, K., Mao, H.Q., Huang, S.K., Leong, K.W., Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:4 (1999), 387–391.
200. Kim, A.R., Kim, H.S., Kim, D.K., Nam, S.T., Kim, H.W., Park, Y.H., Lee, D., Lee, M.B., Lee, J.H., Kim, B., Beaven, M.A., Kim, H.S., Kim, Y.M., Choi, W.S., Mesenteric IL-10-producing CD5+ regulatory B cells suppress cow's milk casein-induced allergic responses in mice. Sci. Rep., 6(November), 2016, 19685.
201. Kang, B., Kim, K.M., Kang, C.Y., Oral tolerance by a high dose OVA in BALB/c mice is more pronounced and persistent in Th2-mediated immune responses than in Th1 responses. Immunobiology 200:2 (1999), 264–276.
202. Strid, J., Thomson, M., Hourihane, J., Kimber, I., Strobel, S., A novel model of sensitization and oral tolerance to peanut protein. Immunology 113:3 (2004), 293–303.
203. Zhou, Y., Kawasaki, H., Hsu, S.-C., Lee, R.T., Yao, X., Plunkett, B., Fu, J., Yang, K., Lee, Y.C., Huang, S.-K., Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat. Med. 16:10 (2010), 1128–1133.
204. Rupa, P., Nakamura, S., Katayama, S., Mine, Y., Attenuation of allergic immune response phenotype by mannosylated egg white in orally induced allergy in BALB/c mice. J. Agric. Food Chem. 62:39 (2014), 9479–9487.
205. Leung, P.S.C., Chu, K.H., Chow, W.K., Ansari, A., Bandea, C.I., Kwan, H.S., Nagy, S.M., Gershwin, M.E., Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen. J. Allergy Clin. Immunol. 94:5 (1994), 882–890.
206. Wai, C.Y., Leung, N.Y., Leung, P.S., Chu, K.H., T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy. Clin. Exp. Allergy 46:3 (2016), 491–503.
207. Yang, M., Yang, C., Mine, Y., Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms. Clin. Exp. Allergy 40:4 (2010), 668–678.
208. Rupa, P., Mine, Y., Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy 67:1 (2012), 74–82.
209. Prickett, S.R., Voskamp, A.L., Dacumos-Hill, A., Symons, K., Rolland, J.M., O'Hehir, R.E., Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic. J. Allergy Clin. Immunol. 127:3 (2011), 608–615.
210. Dioszeghy, V., Mondoulet, L., Puteaux, E., Dhelft, V., Ligouis, M., Plaquet, C., Dupont, C., Benhamou, P.H., Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut. Cell. Mol. Immunol. 13 (2016), 1–13.
211. Burton, O.T., Stranks, A.J., Tamayo, J.M., Koleoglou, K.J., Schwartz, L.B., Oettgen, H.C., A humanized mouse model of anaphylactic peanut allergy. J. Allergy Clin. Immunol. 139:1 (2017), 314–322.
212. Burggraf, M., Nakajima-Adachi, H., Hachimura, S., Ilchmann, A., Pemberton, A.D., Kiyono, H., Vieths, S., Toda, M., Oral tolerance induction does not resolve gastrointestinal inflammation in a mouse model of food allergy. Mol. Nutr. Food Res. 55:10 (2011), 1475–1483.
213. Larena, M., Holmgren, J., Lebens, M., Terrinoni, M., Lundgren, A., Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling. J. Immunol. 194:8 (2015), 3829–3839.
214. Lycke, N., Bemark, M., Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins. Mucosal Immunol. 3:6 (2010), 556–566.
215. Norton, E.B., Lawson, L.B., Freytag, L.C., Clements, J.D., Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin. Vaccine Immunol. 18:4 (2011), 546–551.
216. Sun, J.B., Holmgren, J., Czerkinsky, C., Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. U. S. A. 91:23 (1994), 10795–10799.
217. Rask, C., Holmgren, J., Fredriksson, M., Lindblad, M., Nordström, I., Sun, J.B., Czerkinsky, C., Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin. Exp. Allergy 30:7 (2000), 1024–1032.
218. Sun, J.B., Cuburu, N., Blomquist, M., Li, B.L., Czerkinsky, C., Holmgren, J., Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces foxp3 + CD25 + CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Scand. J. Immunol. 64:3 (2006), 251–259.
219. Bublin, M., Hoflehner, E., Wagner, B., Radauer, C., Wagner, S., Hufnagl, K., Allwardt, D., Kundi, M., Scheiner, O., Wiedermann, U., Breiteneder, H., Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine 25:50 (2007), 8395–8404.
220. Takagi, H., Hiroi, T., Yang, L., Takamura, K., Ishimitsu, R., Kawauchi, H., Takaiwa, F., Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed. Vaccine 26:48 (2008), 6027–6030.
221. Takaiwa, F., Wakasa, Y., Takagi, H., Hiroi, T., Rice seed for delivery of vaccines to gut mucosal immune tissues. Plant Biotechnol. J. 13:8 (2015), 1041–1055.
222. Gloudemans, A.K., Plantinga, M., Guilliams, M., Willart, M.A., Ozir-Fazalalikhan, A., van der Ham, A., Boon, L., Harris, N.L., Hammad, H., Hoogsteden, H.C., Yazdanbakhsh, M., Hendriks, R.W., Lambrecht, B.N., Smits, H.H., The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGFb. PLoS One, 8(3), 2013, e59822.
223. Tamura, S., Hatori, E., Tsuruhara, T., Aizawa, C., Kurata, T., Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 15:2 (1997), 225–229.
224. Lin, I.P., Hsu, Y.S., Kang, S.W., Hsieh, M.H., Wang, J.Y., Escherichia coli heat-labile detoxified enterotoxin modulates dendritic cell function and attenuates allergic airway inflammation. PLoS One, 9(3), 2014, e90293.
225. Eaton-Bassiri, A., Dillon, S.B., Cunningham, M., Rycyzyn, M.A., Mills, J., Sarisky, R.T., Mbow, M.L., Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect. Immun. 72:12 (2004), 7202–7211.
226. Huang, C.F., Wang, C.C., Wu, T.C., Chu, C.H., Peng, H.J., Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice. Ann. Allergy Asthma Immunol. 99:5 (2007), 443–452.
227. Huang, C.F., Wu, T.C., Chu, Y.H., Hwang, K.S., Wang, C.C., Peng, H.J., Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice. Scand. J. Immunol. 68:5 (2008), 502–510.
228. Kitagaki, K., Businga, T.R., Kline, J.N., Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin. Exp. Immunol. 143:2 (2006), 249–259.
229. Hirose, I., Tanaka, H., Takahashi, G., Wakahara, K., Tamari, M., Sakamoto, T., Kojima, S., Inagaki, N., Nagai, H., Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice. Int. Arch. Allergy Immunol. 147:1 (2008), 6–16.
230. Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M.D., Malek, S., Van Uden, J., Martin-Orozco, E., Gelfand, E.W., Raz, E., Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:12 (1998), 7054–7062.
231. Sur, S., Wild, J.S., Choudhury, B.K., Sur, N., Alam, R., Klinman, D.M., Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:10 (1999), 6284–6293.
232. Campbell, J.D., Kell, S.A., Kozy, H.M., Lum, J.A., A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice. Thorax 69:6 (2015), 565–573.
233. Bowman, S.M., Free, S.J., The structure and synthesis of the fungal cell wall. Bioessays 28:8 (2006), 799–808.
234. Bueter, C.L., Specht, C.A., Levitz, S.M., Innate sensing of chitin and chitosan. PLoS Pathog., 9(1), 2013, e1003080.
235. Shibata, Y., Foster, L.A., Bradfield, J.F., Myrvik, Q.N., Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J. Immunol. 164:3 (2000), 1314–1321.
236. Strong, P., Clark, H., Reid, K., Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin. Exp. Allergy 32:12 (2002), 1794–1800.
237. Reese, T.A., Liang, H.-E., Tager, A.M., Luster, A.D., Van Rooijen, N., Voehringer, D., Locksley, R.M., Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447:7140 (2007), 92–96.
238. Lee, C.G., Chitin, chitinases and chitinase-like proteins in allergic inflammation and tissue remodeling. Yonsei Med. J. 50:1 (2009), 22–30.
239. Rao, S., Prestidge, C.A., Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery. Exp. Opin. Drug Deliv. 13:5 (2016), 691–707.
240. Ahmed, T.A., Aljaeid, B.M., Preparation characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des. Dev. Ther. 10 (2016), 483–507.
241. Chen, C.L., Wang, Y.M., Liu, C.F., Wang, J.Y., The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. Biomaterials 29:14 (2008), 2173–2182.
242. Liu, Z., Guo, H., Wu, Y., Yu, H., Yang, H., Li, J., Local nasal immunotherapy: efficacy of dermatophagoides farinae-chitosan vaccine in murine asthma. Int. Arch. Allergy Immunol. 150:3 (2009), 221–228.
243. Saint-Lu, N., Tourdot, S., Razafindratsita, A., Mascarell, L., Berjont, N., Chabre, H., Louise, A., Van Overtvelt, L., Moingeon, P., Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 64:7 (2009), 1003–1013.
244. Chew, J., Wolfowicz, C., Mao, H., Leong, K., Chua, K., Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 21:21–22 (2003), 2720–2729.
245. Li, G.P., Liu, Z.G., Liao, B., Zhong, N.S., Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell. Mol. Immunol. 6:1 (2009), 45–50.
246. Hill, D.A., Artis, D., The influence of commensal bacteria-derived signals on basophil-associated allergic inflammation. Gut Microbes 4:1 (2013), 76–83.
247. Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C., Koga, Y., The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:4 (1997), 1739–1745.
248. Sudo, N., Yu, X.N., Aiba, Y., Oyama, N., Sonoda, J., Koga, Y., Kubo, C., An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin. Exp. Allergy 32:7 (2002), 1112–1116.
249. Oyama, N., Sudo, N., Sogawa, H., Kubo, C., Antibiotic use during infancy promotes a shift in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice. J. Allergy Clin. Immunol. 107:1 (2001), 153–159.
250. Russell, S.L., Gold, M.J., Hartmann, M., Willing, B.P., Thorson, L., Wlodarska, M., Gill, N., Blanchet, M.R., Mohn, W.W., McNagny, K.M., Finlay, B.B., Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 13:5 (2012), 440–447.
251. Repa, A., Grangette, C., Daniel, C., Hochreiter, R., Hoffmann-Sommergruber, K., Thalhamer, J., Kraft, D., Breiteneder, H., Mercenier, A., Wiedermann, U., Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22:1 (2003), 87–95.
252. van Esch, B.C.A.M., Abbring, S., Diks, M.A.P., Dingjan, G.M., Harthoorn, L.F., Vos, A.P., Garssen, J., Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice. Immun. Inflamm. Dis. 4:2 (2016), 155–165.
253. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:2 (2014), 159–166.
254. Schwarzer, M., Srutkova, D., Schabussova, I., Hudcovic, T., Akgün, J., Wiedermann, U., Kozakova, H., Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. Vaccine 31:46 (2013), 5405–5412.
255. Kozakova, H., Schwarzer, M., Tuckova, L., Srutkova, D., Czarnowska, E., Rosiak, I., Hudcovic, T., Schabussova, I., Hermanova, P., Zakostelska, Z., Aleksandrzak-Piekarczyk, T., Koryszewska-Baginska, A., Tlaskalova-Hogenova, H., Cukrowska, B., Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell. Mol. Immunol. 13:2 (2016), 251–262.
256. Van Overtvelt, L., Moussu, H., Horiot, S.P., Samson, S., Lombardi, V., Mascarell, L., van de Moer, A., Bourdet-Sicard, R.I., Moingeon, P., Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 28:17 (2010), 2986–2992.
257. Schabussova, I., Hufnagl, K., Wild, C., Nutten, S., Zuercher, A.W., Mercenier, A., Wiedermann, U., Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine 29:10 (2011), 1981–1990.
258. Daniel, C., Repa, A., Wild, C., Pollak, A., Pot, B., Breiteneder, H., Wiedermann, U., Mercenier, A., Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61:7 (2006), 812–819.
259. Schwarzer, M., Repa, A., Daniel, C., Schabussova, I., Hrncir, T., Pot, B., Stepankova, R., Hudcovic, T., Pollak, A., Tlaskalova-Hogenova, H., Wiedermann, U., Kozakova, H., Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 66:3 (2011), 368–375.
260. Daniel, C., Repa, A., Mercenier, A., Wiedermann, U., Wells, J., The European LABDEL project and its relevance to the prevention and treatment of allergies. Allergy 62:11 (2007), 1237–1242.
261. Ren, C., Zhang, Q., Wang, G., Ai, C., Hu, M., Liu, X., Tian, F., Zhao, J., Chen, Y., Wang, M., Zhang, H., Chen, W., Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice. Appl. Microbiol. Biotechnol. 98:14 (2014), 6353–6364.
262. Frossard, C.P., Steidler, L., Eigenmann, P.A., Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J. Allergy Clin. Immunol. 119:4 (2007), 952–959.
263. Chistiakov, D.A., Bobryshev, Y.V., Kozarov, E., Sobenin, I.A., Orekhov, A.N., Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance. Front. Microbiol., 5, 2014, 781.
264. Bryce, P.J., Balancing tolerance or allergy to food proteins. Trends Immunol. 37:10 (2016), 659–667.
265. Maizels, R.M., Parasitic helminth infections and the control of human allergic and autoimmune disorders. Clin. Microbiol. Infect. 22:6 (2016), 481–486.
266. Bashir, M.E.H., Andersen, P., Fuss, I.J., Shi, H.N., Nagler-Anderson, C., An enteric helminth infection protects against an allergic response to dietary antigen. J. Immunol. 169:6 (2002), 3284–3292.
267. Wang, C.C., Nolan, T.J., Schad, G.A., Abraham, D., Infection of mice with the helminth Strongyloides stercoralis suppresses pulmonary allergic responses to ovalbumin. Clin. Exp. Allergy 31:3 (2001), 495–503.
268. Wohlleben, G., Trujillo, C., Muller, J., Ritze, Y., Grunewald, S., Tatsch, U., Erb, K.J., Helminth infection modulates the development of allergen-induced airway inflammation. Int. Immunol. 16:4 (2004), 585–596.
269. Wagner, A., Forster-Waldl, E., Garner-Spitzer, E., Schabussova, I., Kundi, M., Pollak, A., Scheiner, O., Joachim, A., Wiedermann, U., Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int. J. Parasitol. 39:4 (2009), 465–472.
270. Wagner, A., Schabussova, I., Drinic, M., Akgun, J., Loupal, G., Kundi, M., Joachim, A., Wiedermann, U., Oocyst-derived extract of Toxoplasma gondii serves as potent immunomodulator in a mouse model of birch pollen allergy. PLoS One, 11(5), 2016, e0155081.
271. Schabussova, I., Ul-Haq, O., Hoflehner, E., Akgun, J., Wagner, A., Loupal, G., Joachim, A., Ruttkowski, B., Maizels, R.M., Wiedermann, U., Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice. PLoS One, 8(7), 2013, e67544.
272. Wilson, M.S.M.S., Taylor, M.D.M.D., Balic, A., Finney, C.A.M.C.A.M., Lamb, J.R.J.R., Maizels, R.M.R.M., Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med., 202(9), 2005, 1199.
273. Wilson, M.S., Taylor, M.D., O'Gorman, M.T., Balic, A., Barr, T.A., Filbey, K., Anderton, S.M., Maizels, R.M., Helminth-induced CD19 + CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40:6 (2010), 1682–1696.
274. Blum, A.M., Hang, L., Setiawan, T., Urban, J.P., Stoyanoff, K.M., Leung, J., Weinstock, J.V., Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J. Immunol. 189:5 (2012), 2512–2520.
275. Chenery, A.L., Antignano, F., Burrows, K., Scheer, S., Perona-Wright, G., Zaph, C., Low-dose intestinal Trichuris muris infection alters the lung immune microenvironment and can suppress allergic airway inflammation. Infect. Immun. 84:2 (2015), 491–501.
276. McSorley, H.J., Blair, N.F., Smith, K.A., McKenzie, A.N., Maizels, R.M., Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol. 7:5 (2014), 1068–1078.
277. Abrahamsson, T.R., Wu, R.Y., Jenmalm, M.C., Gut microbiota and allergy: the importance of the pregnancy period. Pediatr. Res. 77:1–2 (2015), 214–219.
278. Straubinger, K., Paul, S., Prazeres da Costa, O., Ritter, M., Buch, T., Busch, D.H., Layland, L.E., Prazeres da Costa, C.U., Maternal immune response to helminth infection during pregnancy determines offspring susceptibility to allergic airway inflammation. J. Allergy Clin. Immunol. 134:6 (2013), 1271–1279.